The purpose of the present study was to evaluate the pharmacokinetic interaction of vitexin rhamnoside (vitexin 2″-α-L-rhamnopyranosyl) and vitexin glucoside (vitexin 2″-β-D-glucopyranosyl) in rats by using a high performance liquid chromatography coupled with tandem mass spectrometry quantitative detection method (LC-MS/MS). The method was validated at the concentration range of 5 - 5000 ng/mL for both vitexin rhamnoside and vitexin glucoside with the regression equations Y = 0.00181X - 0.000955 (r > 0.998) and Y = 0.000788X - 0.000373 (r > 0.997), respectively. The methodological studies (including linearity, intra-assay / inter-assay accuracy and precision) of these two components were investigated. The pharmacokinetic parameters of these two components were compared, which demonstrated their pharmacokinetic variance, especially when they were administrated simultaneously.
Pharmacopoeia Committee of PRC. (2005) Folium Crataegi. Pharmacopoeia of the PRC (Vol. 1). Beijing; 22–23.
2.
LiLD, LiuJX, ShangXH, LiYR, HeXQ, LiuHQ. (1984) Studies on hawthorn and its active principle. I. Effect on myocardial ischemia and hemodynamics in dogs. Journal of Traditional Chinese Medicine, 4, 283–288.
3.
ShanthiS, ParasakthyK, DeepalakshmiPD, DevarajSN. (1994) Hypolipidemic activity of tincture of Crataegus in rats. Indian Journal of Biochemistry and Biophysics, 31, 143–146.
4.
ZhangZ, ChangQ, ZhuM, HuangY, HoWK, ChenZ. (2001) Characterization of antioxidants present in hawthorn fruits. Journal of Nutritional Biochemistry12, 144–152.
ManiscalcoBS, TaylorKA. (2004) Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology, 11, 95–101.
7.
LongSR, CareyRA, CrofootKM, ProteauPJ, FiltzTM (2006) Effect of hawthorn (Crataegus oxycantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay. Phytomedicine, 13, 643–650.
8.
VeverisM, KochE, ChatterjeeSS. (2004) Crataegus special extract WS 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion. Life Science, 74, 1945–1955.
9.
SchusslerM, HolzlJ, FrickeU. (1995) Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung, 45, 842–845.
10.
WeihmayrT, ErnstE. (1996) Therapeutic effectiveness of Crataegus. MMW Fortschritte der Medizin, 114, 27–29.
11.
SvedstromU, VuorelaH, KostiainenR, LaaksoI, HiltunenR. (2006) Fractionation of polyphenols in hawthorn into polymeric procyanidins, phenolic acids and flavonoids prior to high-performance liquid chromatographic analysis. Journal of Chromatography A, 1112, 103–111.
12.
AmmonHP, HandelM. (1981) Crataegus, toxicology and pharmacology. Part II: Pharmacodynamics (author's transl). Planta Medica, 43, 209–239.
MashourNH, LinGI, FrishmanWH (1998) Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Archives of Internal Medicine, 158, 2225–2234.
15.
PittlerMH, SchmidtK, ErnstE. (2003) Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. American Journal of Medicine, 114, 665–674.
16.
WalkerAF, MarakisG, SimpsonE, HopeJL, RobinsonPA, HassaneinM, SimpsonHC (2006) Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. British Journal of General Practice, 56, 437–443.
17.
LiangMJ, XuW, ZhangWD, ZhangC, LiuRH, ShenYH, LiHL, WangXL, WangXW, PanQQ, ChenCL. (2007) Quantitative LC/MS/MS method and in vivo pharmacokinetic studies of vitexin rhamnoside, a bioactive constituent on cardiovascular system from hawthorn. Biomedical Chromatography, 21, 422–429.
18.
SutthanutK, SripanidkulchaiB, YenjaiC, JayM. (2007) Simultaneous identification and quantitation of 11 flavonoid constituents in Kaempferia parviflora by gas chromatography. Journal of Chromatography A, 1143, 227–233.
19.
DiasC, DiasM, BorgesC, Almoster FerreiraMA, PauloA, NascimentoJ. (2003) Structural elucidation of natural 2-hydroxy di-and tricarboxylic acids and esters, phenylpropanoid esters and a flavonoid from Autonoe madeirensis using gas chromatographic/electron ionization, electrospray ionization and tandem mass spectrometric techniques. Journal of Mass Spectrometry, 38, 1240–1244.
20.
NehmeCJ, BastosWL, de AraujoAJ, CavalheiroAJ. (2005) An HPLC-PAD method to analyse flavonoid glycosides and styrylpyrones from Cryptocarya species (Lauraceae). Phytochemistry Analysis, 16, 93–97.
21.
ColomboR, YariwakeJH, QueirozEF, NdjokoK, HostettmannK. (2006) On-line identification of further flavone C- and O-glycosides from sugarcane (Saccharum officinarum L., Gramineae) by HPLC-UV-MS. Phytochemistry Analysis, 17, 337–343.
22.
UrbonaviciuteA, JakstasV, KornysovaO, JanulisV, MaruskaA (2006) Capillary electrophoretic analysis of flavonoids in single-styled hawthorn (Crataegus monogyna Jacq.) ethanolic extracts. Journal of Chromatography A, 1112, 339–344.
23.
WangS, WuY, JuY, ChenX, ZhengW, HuZ. (2003) On-line concentration by field-enhanced sample injection with reverse migrating micelles in micellar electrokinetic capillary chromatography for the analysis of flavonoids in Epimedium brevicornum Maxim. Journal of Chromatography A, 1017, 27–34.
24.
XieLH, WangX, BasnetP, MatsunagaN, YamajiS, YangDY, CaiSQ, TaniT. (2002) Evaluation of variation of acteoside and three major flavonoids in wild and cultivated Scutellaria baicalensis roots by micellar electrokinetic chromatography. Chemical and Pharmaceutical Bulletin, 50, 896–899.
25.
TankanowR, TamerHR, StreetmanDS, SmithSG, WeltonJL, AnnesleyT, AaronsonKD, BleskeBE. (2003) Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). Journal of Clinical Pharmacology, 43, 637–642.
26.
Zai-ChangY, Bo-ChuW, Xiao-ShengY, QiangW. (2005) Chemical composition of the volatile oil from Cynanchum stauntonii and its activities of anti-influenza virus. Colloids and Surface B: Biointerfaces, 43, 198–202.
